Press release
-
Press Release
Virax Biolabs’ CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Virax Biolabs’ proprietary in-development diagnostic technology for post-acute infection syndromes (“PAIS”), such as Long COVID, positions the Company for an…
Read More » -
Press Release
HilltopAds Introduces Dedicated iGaming Feature Suite and Managed Performance Service
LONDON, Dec. 3, 2025 /PRNewswire/ — HilltopAds announced the rollout of a specialized feature set built exclusively for iGaming advertisers,…
Read More » -
Press Release
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma
ZYNLONTA® in combination with glofitamab (COLUMVI®) demonstrated an 89.8% ORR and 77.6% CR across the 49 efficacy-evaluable patients with a…
Read More » -
Press Release
V2X Wins $980 Million IDIQ Contract to Support Global Warfighter Test Systems
RESTON, Va., Dec. 3, 2025 /PRNewswire/ — V2X, Inc. (NYSE: VVX) has been awarded a position on the Automated Test…
Read More » -
Press Release
BTQ Technologies Announces Research Coverage from Leading Digital Asset Research Firm Delphi Digital on Bitcoin Quantum, the Quantum-Safe Bitcoin Network Developed by BTQ
Delphi Digital research coverage: Delphi Digital, a leading independent digital asset research firm, has published an in-depth report on BTQ Technologies…
Read More »